Mirna Therapeutics Announces Pricing of Its Initial Public Offering, 6.250M Shares At $7.00/Share
October 01, 2015 at 07:01 AM EDT
Mirna Therapeutics, Inc., a clinical-stage biopharmaceutical company developing a broad pipeline of microRNA-based oncology ...
